EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail targets tough sarcomas in young patients
Disease control CompletedThis study tested a combination of two chemotherapy drugs, nab-paclitaxel and gemcitabine, in 59 teenagers and young adults whose sarcoma (a type of bone or soft tissue cancer) had returned or not responded to standard treatment. The main goals were to see if the drug combo could…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New stem cell transplant shows promise for kids with tough cancers
Disease control CompletedThis study tested a new way to do stem cell transplants in 23 children with cancers that came back or didn't respond to treatment. The method removes certain immune cells from the donor's stem cells to help the child's body recover faster and fight infections better. The goal was…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo aims to boost survival in bone cancer
Disease control CompletedThis study tested whether adding a drug called topotecan to the standard 5-drug chemotherapy regimen improves outcomes for children and adults with Ewing sarcoma that hasn't spread. 642 participants were randomly assigned to receive either the standard treatment or the standard p…
Matched conditions: EWING SARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental drug cocktail targets tough childhood cancers in adults
Disease control CompletedThis study tested a combination of two drugs, olaparib and temozolomide (with or without irinotecan), in 49 adults with Ewing sarcoma or rhabdomyosarcoma that had come back or spread after standard chemotherapy. The main goal was to find the safest dose and see if the combo could…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Promising new combo tackles tough bone cancer
Disease control CompletedThis study tested two drugs, trabectedin and irinotecan, in 37 people with a type of bone cancer called Ewing sarcoma that had come back or not responded to other treatments. The goal was to find a safe dose and see if the combination could shrink tumors. Participants also receiv…
Matched conditions: EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for young cancer patients: drug shows promise against tough tumors
Disease control CompletedThis study tested the drug lenvatinib in 127 children, adolescents, and young adults whose solid tumors had come back or stopped responding to treatment. The goal was to see if the drug could shrink tumors and to check for side effects. Participants received lenvatinib daily, and…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Leg cancer surgery recovery tracked in new study
Knowledge-focused CompletedThis study followed 100 people who had surgery to remove bone or soft tissue tumors in their leg or pelvis. Researchers measured how independent they became in daily activities and how well their joints moved during the first six months after surgery. The goal was simply to descr…
Matched conditions: EWING SARCOMA
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Real-World data reveals gaps in bone cancer care
Knowledge-focused CompletedThis study looked back at the medical records of 545 patients with bone tumors that had spread (metastatic). The goal was to see how these patients were treated in real life and what their outcomes were. The study focused on three types of bone tumors: osteosarcoma, Ewing sarcoma…
Matched conditions: EWING SARCOMA
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
AI analyzes 700 sarcoma cases to unlock survival secrets
Knowledge-focused CompletedResearchers used machine learning to analyze electronic health records from 700 patients with osteosarcoma or Ewing's sarcoma. The goal was to find patterns in survival and other outcomes. No new treatment was tested; instead, the study aimed to learn from existing data to potent…
Matched conditions: EWING SARCOMA
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Which bone-rebuilding method works best for kids with leg tumors?
Knowledge-focused CompletedThis study looked back at medical records of 91 children who had a malignant bone tumor removed from their leg and then had the bone rebuilt using one of three techniques: induced membrane, vascularized fibula, or vascularized fibula plus a bone graft. The goal was to compare how…
Matched conditions: EWING SARCOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:02 UTC